As expected, the angiogenesis pathway was significantly upregulated in the plasma of TSC-RAML patients, which was in accordance with the pathological process of angiomyolipoma biosynthesis (Xian et al., 2011). This evidence concerns the gene TSC1 and angiomyolipoma.